Atlas Trials

A Single Dose Escalation Study of HHT201 in Healthy Subjects

Clinical trial NCT06373094 · UNKNOWN

Trial details

NCT number
NCT06373094
Sponsor
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2024-06-01
Primary completion
2025-03-31
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.